{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:29:03Z","timestamp":1773286143721,"version":"3.50.1"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"MOMMENTUM CVD"},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council, Singapore","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Discordance among published findings on the plasma concentrations, response dynamics, and clinical associations of plasma neprilysin (NEP) in health and heart failure (HF) require clarification.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Method<\/jats:title>\n                  <jats:p>Using a newly developed glycosylation-sensitive monoclonal antibody sandwich ELISA (NEPCVRI), plasma NEP was measured in 99 non-HF controls, 95 HF patients with preserved ejection fraction, and 104 patients with reduced ejection fraction. Results were compared with those from 2 commercial polyclonal antibody-based AlphaLISA (NEPPE) and ELLA (NEPELLA) immunoassays and a fluorometric activity [NEP activity (NEPACT)] assay.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>NEPCVRI did not correlate with NEPPE, NEPELLA, or NEPACT while the latter 3 assays correlated strongly and directly with each other. Compared with non-HF, NEPCVRI was significantly downregulated in HF, while NEPPE, NEPELLA, and NEPACT were significantly upregulated. Strikingly, NEPCVRI concentration was perturbed by comorbidities (hypertension, diabetes, or atrial fibrillation) and exhibited inverse relationships with clinical variables and functional biomarkers compared with those of NEPPE, NEPELLA, or NEPACT. On univariate and multivariate analyses, NEPPE, NEPELLA, and NEPACT were associated with all-cause death and the composite endpoint of HF admission and all-cause death, while NEPCVRI had no prognostic value.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Plasma NEPCVRI, NEPPE, NEPELLA, and NEPACT display altered dynamics in HF, with NEPCVRI displaying inverse trends to those exhibited by the latter 3 assays. Conflicting data in NEP research may be explained by the heterogeneity of plasma NEP and the antibodies used to detect its varied glycosylated and nonglycosylated fragments. Well-characterized and validated immunoassays are crucial for understanding changes in NEP concentrations and activity in its biological and clinical contexts.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/clinchem\/hvaf056","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T09:23:14Z","timestamp":1747819394000},"page":"800-812","source":"Crossref","is-referenced-by-count":1,"title":["Plasma Neprilysin in Heart Failure: Response Dynamics and Clinical Associations Are Immunoassay Dependent"],"prefix":"10.1093","volume":"71","author":[{"given":"Samantha S M","family":"Ling","sequence":"first","affiliation":[{"name":"Cardiovascular Research Institute, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, National University Health System , Singapore,","place":["Singapore"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shera","family":"Lilyanna","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Institute, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, National University Health System , Singapore,","place":["Singapore"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny P C","family":"Chong","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Institute, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, National University Health System , Singapore,","place":["Singapore"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica Y X","family":"Ng","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Institute, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, National University Health System , Singapore,","place":["Singapore"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siew-Pang","family":"Chan","sequence":"additional","affiliation":[{"name":"Centre for Behavioral and Implementation Science Interventions, Yong Loo Lin School of Medicine, National University of Singapore , Singapore,","place":["Singapore"]},{"name":"National University Heart Centre, National University Health System , Singapore,","place":["Singapore"]},{"name":"Institute of Geriatrics and Active Aging, Tan Tock Seng Hospital , Singapore,","place":["Singapore"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy C R","family":"Prickett","sequence":"additional","affiliation":[{"name":"Christchurch Heart Institute, University of Otago , Christchurch ,","place":["New Zealand"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee Lee","family":"Wong","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Institute, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, National University Health System , Singapore,","place":["Singapore"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2023-8177","authenticated-orcid":false,"given":"A Mark","family":"Richards","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Institute, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, National University Health System , Singapore,","place":["Singapore"]},{"name":"National University Heart Centre, National University Health System , Singapore,","place":["Singapore"]},{"name":"Christchurch Heart Institute, University of Otago , Christchurch ,","place":["New Zealand"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5729-2700","authenticated-orcid":false,"given":"Oi Wah","family":"Liew","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Institute, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, National University Health System , Singapore,","place":["Singapore"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,5,21]]},"reference":[{"key":"2025070409520885600_hvaf056-B1","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jacc.2016.04.060","article-title":"A test in context: neprilysin: function, inhibition and biomarker","volume":"68","author":"Bayes-Genis","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2025070409520885600_hvaf056-B2","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"2025070409520885600_hvaf056-B3","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.bbrc.2014.01.158","article-title":"Production of soluble neprilysin by endothelial cells","volume":"446","author":"Kuruppu","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"2025070409520885600_hvaf056-B4","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/srep01197","article-title":"Human adipose tissue-derived mesenchymal stem cells secrete functional neprilysin-bound exosomes","volume":"3","author":"Katsuda","year":"2013","journal-title":"Sci Rep"},{"key":"2025070409520885600_hvaf056-B5","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1093\/eurheartj\/ehx679","article-title":"The heart regulates the endocrine response to heart failure: cardiac contribution to circulating neprilysin","volume":"39","author":"Arrigo","year":"2018","journal-title":"Eur Heart J"},{"key":"2025070409520885600_hvaf056-B6","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jchf.2019.07.005","article-title":"Circulating neprilysin in patients with heart failure and preserved ejection fraction","volume":"8","author":"Lyle","year":"2020","journal-title":"JACC Heart Fail"},{"key":"2025070409520885600_hvaf056-B7","first-page":"28","article-title":"Altered serum levels of neprilysin in heart failure patients with reduced ejection fraction","volume":"122","author":"Nemcekova","year":"2021","journal-title":"Bratisl Lek Listy"},{"key":"2025070409520885600_hvaf056-B8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.clinbiochem.2022.03.004","article-title":"Finding a reliable assay for neprilysin","volume":"104","author":"Liew","year":"2022","journal-title":"Clin Biochem"},{"key":"2025070409520885600_hvaf056-B9","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s00392-020-01597-x","article-title":"Soluble neprilysin, NT-proBNP, and growth differentiation factor-15 as biomarkers for heart failure in dialysis patients (SONGBIRD)","volume":"109","author":"Claus","year":"2020","journal-title":"Clin Res Cardiol"},{"key":"2025070409520885600_hvaf056-B10","doi-asserted-by":"crossref","first-page":"e015071","DOI":"10.1161\/JAHA.119.015071","article-title":"Plasma neprilysin displays no relevant association with neurohumoral activation in chronic HFrEF","volume":"9","author":"Prausm\u00fcller","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"2025070409520885600_hvaf056-B11","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jchf.2015.03.011","article-title":"Elevated plasma B-type natriuretic peptide concentrations directly inhibit circulating neprilysin activity in heart failure","volume":"3","author":"Vodovar","year":"2015","journal-title":"JACC Heart Fail"},{"key":"2025070409520885600_hvaf056-B12","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jchf.2015.03.010","article-title":"Neprilysin in heart failure from oblivion to centre stage","volume":"3","author":"Bayes-Genis","year":"2015","journal-title":"JACC Heart Fail"},{"key":"2025070409520885600_hvaf056-B13","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.recesp.2015.07.002","article-title":"Multimarker strategy for heart failure prognostication. Value of neurohormonal biomarkers: neprilysin vs NT-proBNP","volume":"68","author":"Bayes-Genis","year":"2015","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"2025070409520885600_hvaf056-B14","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jacc.2014.11.048","article-title":"Soluble neprilysin is predictive of cardiovascular death and heart failure hospitalization in heart failure patients","volume":"65","author":"Bayes-Genis","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2025070409520885600_hvaf056-B15","doi-asserted-by":"crossref","first-page":"e005712","DOI":"10.1161\/JAHA.117.005712","article-title":"Serum neprilysin and recurrent admissions in patients with heart failure","volume":"6","author":"N\u00fa\u00f1ez","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"2025070409520885600_hvaf056-B16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/ejhf.435","article-title":"Soluble neprilysin does not correlate with outcome in heart failure with preserved ejection fraction","volume":"18","author":"Goliasch","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2025070409520885600_hvaf056-B17","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s00018-023-05083-1","article-title":"Multiple circulating forms of neprilysin detected with novel epitope-directed monoclonal antibodies","volume":"81","author":"Ling","year":"2024","journal-title":"Cell Mol Life Sci"},{"key":"2025070409520885600_hvaf056-B18","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1373\/clinchem.2015.252932","article-title":"High sensitivity sandwich ELISA for plasma NT-proUcn2: plasma levels and relationship to mortality in heart failure","volume":"62","author":"Liew","year":"2016","journal-title":"Clin Chem"},{"key":"2025070409520885600_hvaf056-B19","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.healun.2015.12.015","article-title":"Soluble neprilysin retains catalytic activity in heart failure","volume":"35","author":"Bayes-Genis","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"2025070409520885600_hvaf056-B20","doi-asserted-by":"crossref","first-page":"46172","DOI":"10.1074\/jbc.M407333200","article-title":"A three-dimensional model of the neprilysin 2 active site based on the X-ray structure of neprilysin: identification of residues involved in substrate hydrolysis and inhibitor binding of neprilysin 2","volume":"279","author":"Voisin","year":"2004","journal-title":"J Biol Chem"},{"key":"2025070409520885600_hvaf056-B21","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/B978-0-12-382219-2.00128-9","volume-title":"Handbook of proteolytic enzymes","author":"Marr","year":"2013","edition":"3rd Ed"},{"key":"2025070409520885600_hvaf056-B22","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13098-023-01053-6","article-title":"Leveraging IgG N-glycosylation to infer the causality between TD2 and hypertension","volume":"15","author":"Wang","year":"2023","journal-title":"Diabetol Metab Syndr"},{"key":"2025070409520885600_hvaf056-B23","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/1873-3468.13495","article-title":"Altered N-glycosylation profiles as potential biomarkers and drug targets in diabetes","volume":"593","author":"Rudman","year":"2019","journal-title":"FEBS Lett"},{"key":"2025070409520885600_hvaf056-B24","doi-asserted-by":"crossref","first-page":"117298","DOI":"10.1016\/j.cca.2023.117298","article-title":"N-glycosylation of serum proteins in adult type 1 diabetes mellitus exposes further changes compared to children at the disease onset","volume":"543","author":"Nem\u010di\u0107","year":"2022","journal-title":"Clin Chim Acta"},{"key":"2025070409520885600_hvaf056-B25","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3390\/biom13040605","article-title":"The N-glycosylation of total plasma proteins and IgG in atrial fibrillation","volume":"13","author":"Plav\u0161a","year":"2023","journal-title":"Biomolecules"},{"key":"2025070409520885600_hvaf056-B26","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s10719-015-9626-2","article-title":"Human plasma protein N-glycosylation","volume":"33","author":"Clerc","year":"2016","journal-title":"Glycoconj J"},{"key":"2025070409520885600_hvaf056-B27","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.arr.2012.02.002","article-title":"N-glycomic biomarkers of biological aging and longevity: a link with inflammaging","volume":"12","author":"Dall\u2019Olio","year":"2013","journal-title":"Ageing Res Rev"},{"key":"2025070409520885600_hvaf056-B28","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/gerona\/glt190","article-title":"Glycans are a novel biomarker of chronological and biological ages","volume":"69","author":"Kri\u0161ti\u0107","year":"2014","journal-title":"J Gerontol A Biol Sci Med Sci"}],"container-title":["Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/clinchem\/article-pdf\/71\/7\/800\/63257590\/hvaf056.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/clinchem\/article-pdf\/71\/7\/800\/63257590\/hvaf056.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T13:52:18Z","timestamp":1751637138000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/clinchem\/article\/71\/7\/800\/8139734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,21]]},"references-count":28,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,5,21]]},"published-print":{"date-parts":[[2025,7,4]]}},"URL":"https:\/\/doi.org\/10.1093\/clinchem\/hvaf056","relation":{},"ISSN":["0009-9147","1530-8561"],"issn-type":[{"value":"0009-9147","type":"print"},{"value":"1530-8561","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,7]]},"published":{"date-parts":[[2025,5,21]]}}}